Metabolic effects of spirapril and atenolol: Results from a randomized, long-term study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 6, 1997, Pages 227-230

  Hakamaki T ^a   Lehtonen, A ^a  

^a TURKU CITY HOSPITAL   (Finland)

Author keywords

Atenolol; Metabolic effects; Spirapril

Indexed keywords

APOLIPOPROTEIN A1; ATENOLOL; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; SPIRAPRIL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VERTIGO;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 1842373856     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ames RP 1986 The effects of antihypertensive drugs on serum lipids and lipoproteins. Drugs 32: 335-357
2. 1 adrenoceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity. J Hum Hypertens 8: 219-226
3. Berne C, Pollare T, Lithell H 1991 Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 14: 39-47
4. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Granziadei L, Pedrinelli R, Brandi L, Bevilacqua S 1987 Insulin resistance in essential hypertension. N Engl J Med 317: 350-357
5. De Franzo RA, Ferrannini E 1991 Insulin resistance, a multifacetial syndrome responsible for NIDDM, obesity, hypertension, dyslipidemic, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
6. Jaunch K-W, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G 1987 Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin dependent diabetes mellitus. Eur J Clin Invest 17: 448-454
7. Lehtonen A 1985 Effect of beta-blockers on plasma lipids during antihypertensive therapy. J Cardiovasc Pharmacol 7: 110S-114S
8. Lehtonen A, Marniemi J 1984 Effect of atenolol on plasma HDL subtractions. Atherosclerosis 51: 335-338
9. Leren P, Foss PO, Nordvil B, Fossbalek B 1988 The effect of enalapril and timolol on blood lipids. Acta Med Scand 223: 321-326
10. Lind L, Pollare T, Berne C, Lithell H 1994 Long-term metabolic effects of antihypertensive drugs. Am Heart J 128: 1177-1183
11. Lithell HO 1991 Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 14: 203-209
12. Multiple Risk Factor Intervention Trial Research Group 1985 Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups. Arch Intern Med 145: 1191-1199
13. Pollare T, Lithell A, Mörlin C, Präntare H, Hvarner A, Ljunghall S 1989 Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertension 7: 551-559
14. Reneland R, Andersson P-E, Haenni A, Lithell H 1994 Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition. Eur J Clin Pharmacol 46: 431-436
15. Rössner S, Weiner L 1983 Atenolol and metoprolol - Comparison of effects on blood pressure and serum lipoproteins and side effects. Eur J Clin Pharmacol 24: 573-577